CD4 and arteriosclerosis: Importantly, as we recently demonstrated in a clinically relevant humanised model of transplant arteriosclerosis, ex vivo expanded CD25hiCD4+ and CD127loCD25+CD4+ Treg cells have been very effective in inhibiting vasculopathy, with CD127loCD25+CD4+ cells being five times more efficient than conventional Treg [32••].